Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (591-600 of 1,016) with videos related to

Pageof 102
Sort By:
Journal of Pain and Symptom Management|September 29, 2012
Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22)Timothy P Pearman, Jennifer L Beaumont, Diane Paul, et al.
Cancer|March 23, 2016
Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinomaJennifer L Beaumont, John M Salsman, Jose Diaz, et al.
The Journal of Supportive Oncology|October 20, 2007
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstrationKimberly Davis, Susan Yount, Katie Del Ciello, et al.
Journal of Clinical Epidemiology|October 27, 2004
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scaleDavid T Eton, David Cella, Kathleen J Yost, et al.
Journal of Pediatric Psychology|November 28, 2019
Pragmatic Health Assessment in Early Childhood: The PROMIS® of Developmentally Based Measurement for Pediatric PsychologyCourtney K Blackwell, Lauren Wakschlag, Sheila Krogh-Jespersen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2013
Psychometric validation of the functional assessment of cancer therapy--brain (FACT-Br) for assessing quality of life in patients with brain metastasesNemica Thavarajah, Gillian Bedard, Liying Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2013
Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohortAndrew M Naidech, Jennifer L Beaumont, Neil F Rosenberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 13, 2021
Correlates of financial toxicity in adult cancer patients and their informal caregiversGelareh Sadigh, Jeffrey Switchenko, Kathryn E Weaver, et al.
Medicine|November 22, 2018
Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey studyDaniel M Halperin, Lynn Huynh, Jennifer L Beaumont, et al.
Journal of Pain and Symptom Management|August 12, 2017
Computerized Adaptive Testing in Pediatric Brain Tumor ClinicsJin-Shei Lai, Jennifer L Beaumont, Cindy J Nowinski, et al.
Pageof 102

Showing results (591-600 of 1,016) with videos related to

Sort By:
Pageof 102
Journal of Pain and Symptom Management|September 29, 2012
Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22)Timothy P Pearman, Jennifer L Beaumont, Diane Paul, et al.
Cancer|March 23, 2016
Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinomaJennifer L Beaumont, John M Salsman, Jose Diaz, et al.
The Journal of Supportive Oncology|October 20, 2007
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstrationKimberly Davis, Susan Yount, Katie Del Ciello, et al.
Journal of Clinical Epidemiology|October 27, 2004
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scaleDavid T Eton, David Cella, Kathleen J Yost, et al.
Journal of Pediatric Psychology|November 28, 2019
Pragmatic Health Assessment in Early Childhood: The PROMIS® of Developmentally Based Measurement for Pediatric PsychologyCourtney K Blackwell, Lauren Wakschlag, Sheila Krogh-Jespersen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2013
Psychometric validation of the functional assessment of cancer therapy--brain (FACT-Br) for assessing quality of life in patients with brain metastasesNemica Thavarajah, Gillian Bedard, Liying Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2013
Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohortAndrew M Naidech, Jennifer L Beaumont, Neil F Rosenberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 13, 2021
Correlates of financial toxicity in adult cancer patients and their informal caregiversGelareh Sadigh, Jeffrey Switchenko, Kathryn E Weaver, et al.
Medicine|November 22, 2018
Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey studyDaniel M Halperin, Lynn Huynh, Jennifer L Beaumont, et al.
Journal of Pain and Symptom Management|August 12, 2017
Computerized Adaptive Testing in Pediatric Brain Tumor ClinicsJin-Shei Lai, Jennifer L Beaumont, Cindy J Nowinski, et al.
Pageof 102